Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2026-03-01 @ 12:26 PM
Study NCT ID:
NCT04763408
Status:
COMPLETED
Last Update Posted:
2024-07-18
First Post:
2021-02-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Safety and Tolerability of Lenvatinib in Participants With Advanced or Unresectable Hepatocellular Carcinoma
Sponsor:
Eisai Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-09
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-13
Completion Date Type:
ACTUAL
First Submit Date:
2021-02-17
First Submit QC Date:
None
Study First Post Date:
2021-02-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-17
Last Update Post Date:
2024-07-18
Last Update Post Date Type:
ACTUAL